Clinical Trials Directory

Trials / Completed

CompletedNCT02500394

Biomarker Guided Intervention for Prevention of Acute Kidney Injury

Biomarker Guided Intervention to Prevent Development of Acute Kidney Injury in High-risk Surgical Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
135 (actual)
Sponsor
University Hospital Regensburg · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the impact of a biomarked guided intervention on the development of acute kidney injury in high risk surgical patients. Eligible patients are screened for marker of tubular stress in the urine; if patient specific results are above a pre-defined cutoff they are randomized into a standard care group or an interventional group in which patients receive intensified volume therapy.

Detailed description

This study evaluates the impact of a biomarked guided intervention on the development of acute kidney injury in high risk surgical patients.Used markers have been identified as markers of tubular stress and have been validated in previous studies with more than 1500 patients. The advantage of a biomarker guided approach is the saving of time for the diagnosis a developing acute kidney injury (AKI) in high risk surgical patients, since clinical signs of AKI (rise in creatinine/decline of estimated Glomerular Filtration Rate (eGFR), decline of diuresis). If used biomarkers are above a predefined cutoff within \< 4 hours after surgery, patients are randomized in to a standard care population receiving treatment in accordance with Kidney Disease Improving Global Outcomes (KDIGO) guidelines. In the intervention population patients receive individual volume therapy (= balanced electrolyte solution (Ionosteril)) (1,25 ml/kg bw up to 5 ml/kg bw for 6 hours). Degree of volume therapy is estimated by several predifined parameters, e.g. central venous pressure (CVP).

Conditions

Interventions

TypeNameDescription
PROCEDUREIonosterilbiomarker guided volume substitution with Ionosteril

Timeline

Start date
2015-06-01
Primary completion
2016-12-01
Completion
2017-01-01
First posted
2015-07-16
Last updated
2017-05-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02500394. Inclusion in this directory is not an endorsement.